James P. Maloney - Mar 16, 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chief Financial Officer
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Mar 16, 2023
Transactions value $
-$20,555
Form type
4
Date filed
5/1/2023, 08:48 AM
Previous filing
Jul 22, 2022
Next filing
Jul 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability -$12.8K -123 -4.18% $104.46 2.82K Mar 16, 2023 Direct
transaction MED Common Stock Tax liability -$7.71K -75 -2.66% $102.75 2.75K Mar 17, 2023 Direct
transaction MED Common Stock Award $0 +4.57K +166.57% $0.00 7.32K Mar 17, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.